XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (7122)	9/2/1998 10:52:00 AM
From: Bluegreen	Read Replies (1) of 17367

Bob, several questions. Is the deal with the FDA 200 patients and two years? In other words does it have to run two years? Since there are well over 200 patients enrolled, could Xoma stop trial itself if DSMB does not halt for approval? Now remember I am aware that more patients the better enrolled but that is a luxury that might be played off the dismal stock price? Why not take the chance right after DSMB(IF they say no safety concerns and continue) if you could considering the stock price? Do you think this has anything to do with the survey? Are they concerned of tax driven selling if DSMB says just continue?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next